Akari Therapeutics, Peak Bio: Post-merger Bd of Directors Will Consist of 3 Directors Selected by Each Co and 1 Independent Director Jointly Selected >AKTX
Akari Therapeutics, Peak Bio: Post-merger Bd of Directors Will Consist of 3 Directors Selected by Each Co and 1 Independent Director Jointly Selected >AKTX
Akari Therapeutics、Peak Bio：合并后的董事名单将由每家公司选出的3名董事和共同选出的1名独立董事组成 >AKTX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册